Cargando…
Immunostaining of stromal CD56 cells in ovarian malignancies
OBJECTIVES: The aim of this study was to evaluate CD56 immunostaining in the stroma of benign and malignant ovarian epithelial neoplasms and associate the CD56 immunostaining with prognostic factors and survival in ovarian cancer. METHODS: Patients with ovarian epithelial neoplasia (n=77) were studi...
Autores principales: | de Lima, Cid Almeida, Jammal, Millena Prata, Etchebehere, Renata Margarida, Murta, Eddie Fernando Candido, Nomelini, Rosekeila Simões |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Médica Brasileira
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185054/ https://www.ncbi.nlm.nih.gov/pubmed/37194901 http://dx.doi.org/10.1590/1806-9282.20220992 |
Ejemplares similares
-
Is Ovarian Cancer Prevention Currently Still a recommendation of Our Grandparents?
por: Jammal, Millena Prata, et al.
Publicado: (2017) -
Cytokines and Prognostic Factors in Epithelial Ovarian Cancer
por: Jammal, Millena Prata, et al.
Publicado: (2016) -
Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms
por: JAMMAL, MILLENA PRATA, et al.
Publicado: (2015) -
Abdominopelvic Tuberculosis with a Frozen Section Analysis Consistent with Ovarian Cancer
por: Martins-Filho, Agrimaldo, et al.
Publicado: (2017) -
Parameters of Blood Count and Tumor Markers in Patients with Borderline Ovarian Tumors: A Retrospective Analysis and Relation to Staging
por: Nomelini, Rosekeila Simões, et al.
Publicado: (2012)